Life-Sustaining Treatment Ends Sooner for Uninsured Trauma Patients
By Lori Solomon HealthDay Reporter
FRIDAY, Aug. 2, 2024 -- Early withdrawal of life-sustaining therapy (WLST) is more likely among uninsured trauma patients, according to a study published online July 24 in JAMA Network Open.
Graeme Hoit, M.D., from the University of Toronto, and colleagues assessed if patient insurance type (private insurance, Medicaid, and uninsured) is associated with time to WLST in critically injured adults treated at U.S. trauma centers. The analysis included 307,731 patients injured between Jan. 1, 2017, and Dec. 31, 2020.
The researchers found that 4.2 percent of patients underwent WLST during their admission. Earlier WLST was significantly more likely among patients who were uninsured versus those with private insurance (hazard ratio, 1.54) and Medicaid (hazard ratio, 1.47). When excluding patients who died within 48 hours of presentation and after accounting for nonwithdrawal death as a competing risk, findings persisted.
"In this cohort study of U.S. adult trauma patients who were critically injured, patients who were uninsured underwent earlier WLST compared with those with private or Medicaid insurance," the authors write. "Based on our findings, a patient’s ability to pay was likely associated with a shift in decision-making for WLST, suggesting that socioeconomic status affects patient outcomes."
One author disclosed ties to the medical technology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.